Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Research Group
Cancer Biomarkers
City of Hope Medical Center
Recruiting ID
For more information, see NCT03303846
This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.
Magnetic Resonance Imaging, Biospecimen Collection, Laboratory Biomarker Analysis
Healthy Subject
Victoria Seewaldt, MD, Julie E. Lang, MD, Ruth O'Regan, MD, Terry Hyslop, PhD, Steven K. Clinton, MD, Lisa Yee, MD, Renae Quale, Tanya Chavez, Sarah Woelke, Kristy Watkins, Jennifer Gallagher

See list of participating sites